Market By Product & Services, Technology, Application And Geography | Forecast 2019-2028
We provide additional customization based on your specific requirements. Request For Customization
The countries evaluated in the North American protein sequencing market are:
•    Canada
•    The United States
The biotechnology industry in Canada is expected to witness high revenue growth in the next five years. The government plays an essential role in this growth and in securing product development and commercial success in the sector. Among the several government-initiated programs, the Scientific Research & Experimental Development Program was the most accessed program, with 72% of respondents benefiting from the program.
The Canadian biotechnology sector is concentrated in three provinces, namely, Quebec, Ontario and British Columbia, accounting for approximately 75% of all biotechnology companies in Canada. As protein sequencing finds its applications in the biotechnology sector, the growth in this sector will consequently lead to the development of the protein sequencing market in the country.
Likewise, biologics remains to become increasingly dominant in the country, considering the total market share. The sector is an exceptional driver of the protein sequencing market growth. Pharmaceutical companies are adopting strategies to minimize risk and overcome their poor pipeline productivity. Besides, adequate capital access is likely to impact the productivity of small and medium corporations, thereby influencing their development in the coming years. These strategical initiatives are expected to contribute to the growth of the protein sequencing market in Canada.
Agilent Technologies is a company that provides instruments, software, services and consumables solutions. It serves its product and services to clinical and routine diagnostics and analytical laboratories. The company offers its services to different markets, including life sciences research, environmental & forensics, chemical & energy, food & diagnostics & clinical market. Headquartered in Santa Clara, California, the US, the company operates Europe, Asia-Pacific and North America.
1.   NORTH AMERICA PROTEIN SEQUENCING MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCE ANALYSIS
2.2.1.  THREAT OF NEW ENTRANTS
2.2.2.  THREAT OF SUBSTITUTE
2.2.3.  BARGAINING POWER OF SUPPLIERS
2.2.4.  BARGAINING POWER OF BUYERS
2.2.5.  THREAT OF COMPETITIVE RIVALRY
2.3. MARKET ATTRACTIVENESS INDEX
2.4. VENDOR SCORECARD
2.5. IMPACT OF COVID ON PROTEIN SEQUENCING
2.6. MARKET DRIVERS
2.6.1.  INCREASED EMPHASIS ON TARGET-BASED DRUG DEVELOPMENT
2.6.2.  ADVANCEMENTS IN MASS SPECTROMETRY AND ANALYTICAL TECHNIQUES
2.7. MARKET RESTRAINTS
2.7.1.  LACK OF PROFICIENT RESEARCHERS AND LABORATORY PROFESSIONALS
2.8. MARKET OPPORTUNITIES
2.8.1.  DEVELOPMENTS IN COMPUTATIONAL PROTEOMICS
2.8.2.  BIOPHARMACEUTICALS IS THE FASTEST-GROWING SEGMENT
2.9. MARKET CHALLENGES
2.9.1.  HEAVY COSTS LEVIED ON MASS SPECTROMETRY EQUIPMENT
3.   NORTH AMERICA PROTEIN SEQUENCING MARKET OUTLOOK - BY PRODUCT & SERVICES
3.1. REAGENTS AND CONSUMABLES
3.2. INSTRUMENTS
3.2.1.  EDMAN DEGRADATION
3.2.2.  MASS SPECTROMETRY
3.3. ANALYSIS PRODUCT
3.4. PROTEIN SEQUENCING SERVICES
4.   NORTH AMERICA PROTEIN SEQUENCING MARKET OUTLOOK - BY TECHNOLOGY
4.1. MASS SPECTROMETRY
4.2. EDMAN DEGRADATION
5.   NORTH AMERICA PROTEIN SEQUENCING MARKET OUTLOOK - BY APPLICATION
5.1. ACADEMIA
5.2. BIOPHARMACEUTICALS
5.3. BIOTECHNOLOGY RESEARCH
6.   NORTH AMERICA PROTEIN SEQUENCING MARKET – REGIONAL OUTLOOK
6.1. UNITED STATES
6.2. CANADA
7.   COMPETITIVE LANDSCAPE
7.1. SHIMADZU CORPORATION
7.2. AGILENT TECHNOLOGIES INC
7.3. THERMOFISHER SCIENTIFIC INC
7.4. PROTEOME FACTORY
7.5. WATER CORPORATION
7.6. BIOINFORMATICS SOLUTIONS INC
7.7. CHARLES RIVERÂ Â
7.8. SELVITA
7.9. RAPID NOVOR INC
7.10. SGS SA
7.11. BRUKER
7.12. TAKARA BIO INC
8.   METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICES, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICES, 2019 & 2028 (IN %)
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY REAGENTS AND CONSUMABLES, 2019-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY EDMAN DEGRADATION, 2019-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY MASS SPECTROMETRY, 2019-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY ANALYSIS PRODUCT 2019-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY PROTEIN SEQUENCING SERVICES, 2019-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY MASS SPECTROMETRY, 2019-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY EDMAN DEGRADATION, 2019-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY ACADEMIA, 2019-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY BIOPHARMACEUTICALS, 2019-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA PROTEIN SEQUENCING MARKET, BY BIOTECHNOLOGY RESEARCH, 2019-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA PROTEIN SEQUENCING MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 15: UNITED STATES PROTEIN SEQUENCING MARKET, 2019-2028 (IN $ MILLION)
FIGURE 16: CANADA PROTEIN SEQUENCING MARKET, 2019-2028 (IN $ MILLION)